Dis-Chem Pharmacies Limited (JSE: DCP)
South Africa
· Delayed Price · Currency is ZAR 3,669.00
+28.00 (0.77%)
Dec 20, 2024, 5:00 PM SAST
Dis-Chem Pharmacies Cash Flow Statement
Financials in millions ZAR. Fiscal year is March - February.
Millions ZAR. Fiscal year is Mar - Feb.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Aug '24 Aug 31, 2024 | Feb '24 Feb 29, 2024 | Feb '23 Feb 28, 2023 | Feb '22 Feb 28, 2022 | Feb '21 Feb 28, 2021 | Feb '20 Feb 29, 2020 | 2019 - 2015 |
| Net Income | 1,061 | 984.48 | 1,000 | 853.45 | 668.69 | 598.23 | Upgrade
|
| Depreciation & Amortization | 1,034 | 998.02 | 941.15 | 792.43 | 665.27 | 552.9 | Upgrade
|
| Other Amortization | 63.92 | 63.92 | 60.96 | 62.16 | 39.69 | 22.86 | Upgrade
|
| Loss (Gain) From Sale of Assets | -0.69 | -0.69 | 1.92 | 6.82 | 0.18 | -0.26 | Upgrade
|
| Loss (Gain) on Equity Investments | -45.27 | -45.27 | -22.78 | -1.19 | -3 | -0.2 | Upgrade
|
| Stock-Based Compensation | 24.23 | 24.23 | 20.82 | 18.58 | 6.41 | 7.96 | Upgrade
|
| Provision & Write-off of Bad Debts | 1.63 | 1.63 | 4.79 | 6.54 | 0.81 | -0.35 | Upgrade
|
| Other Operating Activities | 118.15 | 39.24 | 31.24 | 52.71 | 120.72 | 76.55 | Upgrade
|
| Change in Accounts Receivable | -148.49 | -148.49 | -374.61 | -186.77 | -248.24 | -296.21 | Upgrade
|
| Change in Inventory | -802.7 | -802.7 | -578.18 | 66.43 | -1,018 | 648.15 | Upgrade
|
| Change in Accounts Payable | 712.36 | 712.36 | 223.84 | 115.94 | 996.25 | -67.5 | Upgrade
|
| Change in Other Net Operating Assets | -97.44 | 63.48 | 10.58 | 49.05 | -65.26 | -18.76 | Upgrade
|
| Operating Cash Flow | 1,921 | 1,890 | 1,320 | 1,836 | 1,164 | 1,523 | Upgrade
|
| Operating Cash Flow Growth | 23.55% | 43.20% | -28.11% | 57.80% | -23.62% | 71.66% | Upgrade
|
| Capital Expenditures | -1,078 | -1,027 | -1,090 | -377.27 | -401.19 | -363.35 | Upgrade
|
| Sale of Property, Plant & Equipment | 18.88 | 17.1 | 22.81 | 8.31 | 12.24 | 10.06 | Upgrade
|
| Cash Acquisitions | -155.94 | -55.18 | -43.53 | -265.75 | -394.32 | -43.92 | Upgrade
|
| Divestitures | - | - | -1.19 | - | - | - | Upgrade
|
| Investment in Securities | 33.92 | 31.45 | 21.21 | -160.85 | 3.52 | -16 | Upgrade
|
| Investing Cash Flow | -1,192 | -1,065 | -1,091 | -795.56 | -779.75 | -413.22 | Upgrade
|
| Long-Term Debt Issued | - | 1,201 | 1,317 | 536.53 | 102.85 | 900 | Upgrade
|
| Long-Term Debt Repaid | - | -1,329 | -1,491 | -941.66 | -552.63 | -918.08 | Upgrade
|
| Net Debt Issued (Repaid) | -180.46 | -127.99 | -174.63 | -405.13 | -449.78 | -18.08 | Upgrade
|
| Repurchase of Common Stock | -14.5 | -65.49 | -28.53 | -12.17 | - | -13.15 | Upgrade
|
| Common Dividends Paid | -448.52 | -424.33 | -466.01 | -458.57 | -39.5 | -266.39 | Upgrade
|
| Other Financing Activities | -10.13 | -14.03 | - | -27.31 | -48.35 | -30.21 | Upgrade
|
| Financing Cash Flow | -653.61 | -631.83 | -669.16 | -903.17 | -537.63 | -327.82 | Upgrade
|
| Foreign Exchange Rate Adjustments | 5.46 | -0.24 | -1.17 | 7.62 | -10.66 | -1.01 | Upgrade
|
| Net Cash Flow | 81.04 | 193.4 | -441.02 | 145.04 | -164.46 | 781.32 | Upgrade
|
| Free Cash Flow | 842.56 | 863.11 | 230 | 1,459 | 762.39 | 1,160 | Upgrade
|
| Free Cash Flow Growth | -3.80% | 275.26% | -84.23% | 91.36% | -34.28% | 135.34% | Upgrade
|
| Free Cash Flow Margin | 2.22% | 2.38% | 0.70% | 4.80% | 2.90% | 4.84% | Upgrade
|
| Free Cash Flow Per Share | 0.98 | 1.01 | 0.27 | 1.70 | 0.89 | 1.35 | Upgrade
|
| Cash Interest Paid | 503.01 | 457.38 | 363.36 | 330.96 | 335.28 | 383.93 | Upgrade
|
| Cash Income Tax Paid | 414.76 | 381.61 | 381.31 | 301.07 | 235.44 | 231.83 | Upgrade
|
| Levered Free Cash Flow | 665.19 | 725.14 | 149.96 | 1,413 | 651.86 | 1,011 | Upgrade
|
| Unlevered Free Cash Flow | 985.78 | 1,017 | 381.49 | 1,616 | 867.22 | 1,263 | Upgrade
|
| Change in Net Working Capital | 265.98 | 154.57 | 642.24 | -156.52 | 274.85 | -229.24 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.